本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.26
+0.20501.86%
成交量:5,667
成交額:6.34萬
市值:3.93億
市盈率:-10.16
高:11.35
開:11.09
低:11.09
收:11.05
52周最高:16.76
52周最低:9.85
股本:3,488.27萬
流通股本:1,845.34萬
量比:0.49
換手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):-1.1074
每股收益(LYR):-0.9800
淨資產收益率:-33.21%
總資產收益率:-22.67%
市淨率:2.22
市盈率(LYR):-11.48

資料載入中...

2024/03/02

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/12/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/30

重要事件披露

Form 8-K - Current report
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/17

重要事件披露

Form 8-K - Current report
2023/09/28

重要事件披露

Form 8-K - Current report
2023/09/21

重要事件披露

Form 8-K - Current report
2023/09/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/09/19

重要事件披露

Form 8-K - Current report
2023/09/11

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]